Skip to main content

Effects of fondaparinux in patients with ST-Segment elevation acute myocardial infarction non-eligible for reperfusion treatment

Publication ,  Conference
Wallentin, LC; Mehta, SR; Afzal, R; Chrolavicius, S; Granger, CB; Budaj, A; Peters, RJ; Bassand, J-P; Fox, KA; Yusuf, S
Published in: CIRCULATION
October 31, 2006

Duke Scholars

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 31, 2006

Volume

114

Issue

18

Start / End Page

699 / 700

Location

Chicago, IL

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

79th Annual Scientific Session of the American-Heart-Association

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wallentin, L. C., Mehta, S. R., Afzal, R., Chrolavicius, S., Granger, C. B., Budaj, A., … Yusuf, S. (2006). Effects of fondaparinux in patients with ST-Segment elevation acute myocardial infarction non-eligible for reperfusion treatment. In CIRCULATION (Vol. 114, pp. 699–700). Chicago, IL: LIPPINCOTT WILLIAMS & WILKINS.
Wallentin, Lars C., Shamir R. Mehta, Rizwan Afzal, Susan Chrolavicius, Christopher B. Granger, Andrzej Budaj, Ron J. Peters, Jean-Pierre Bassand, Keith A. Fox, and Salim Yusuf. “Effects of fondaparinux in patients with ST-Segment elevation acute myocardial infarction non-eligible for reperfusion treatment.” In CIRCULATION, 114:699–700. LIPPINCOTT WILLIAMS & WILKINS, 2006.
Wallentin LC, Mehta SR, Afzal R, Chrolavicius S, Granger CB, Budaj A, et al. Effects of fondaparinux in patients with ST-Segment elevation acute myocardial infarction non-eligible for reperfusion treatment. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2006. p. 699–700.
Wallentin, Lars C., et al. “Effects of fondaparinux in patients with ST-Segment elevation acute myocardial infarction non-eligible for reperfusion treatment.” CIRCULATION, vol. 114, no. 18, LIPPINCOTT WILLIAMS & WILKINS, 2006, pp. 699–700.
Wallentin LC, Mehta SR, Afzal R, Chrolavicius S, Granger CB, Budaj A, Peters RJ, Bassand J-P, Fox KA, Yusuf S. Effects of fondaparinux in patients with ST-Segment elevation acute myocardial infarction non-eligible for reperfusion treatment. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2006. p. 699–700.

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 31, 2006

Volume

114

Issue

18

Start / End Page

699 / 700

Location

Chicago, IL

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

79th Annual Scientific Session of the American-Heart-Association

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology